Signals, Powered By EquityPandit
Suven Life Science has been approved a patent by the US for a drug to cure neuro- degenerative diseases.
Suven Life has said in a BSE filing that it has been granted “one product patent from the US corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases.”
It added that the patents are valid till 2034.
Venkat Jasti, Suven Life CEO has said that “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally.”
